LncRNA SNHG10 is downregulated in non-small cell lung cancer and predicts poor survival

被引:20
作者
Liang, Meng [1 ]
Wang, Linlin [2 ]
Cao, Chuanhua [3 ]
Song, Shimao [1 ]
Wu, Feng [1 ]
机构
[1] Hubei Univ Med, Taihe Hosp, Dept Oncol, 32 South Renmin Rd, Shiyan 442000, Hubei, Peoples R China
[2] Hubei Univ Med, Renmin Hosp, Dept Radiol, Shiyan 442000, Hubei, Peoples R China
[3] Hubei Univ Arts & Sci, Xiangyang Cent Hosp, Affiliated Hosp, Dept Oncol, Xiangyang 441021, Hubei, Peoples R China
关键词
SNHG10; miR-21; NSCLC; Methylation; PROLIFERATION; BIOMARKER; THERAPY;
D O I
10.1186/s12890-020-01281-w
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background LncRNA SNHG10 has been reported to be an oncogenic lncRNA in liver cancer. However, its roles in non-small cell lung cancer (NSCLC) remains unknown. Methods Tumor and paired non-tumor tissues were harvested from 62 NSCLC patients. RT-qPCR was used to detect the expression of SNHG10 and miR-21 in tissues. Overexpression experiments were used to evaluate the interaction between SNHG10 and miR-21 in NSCLC cells. CCK-8 assay was used to detect the cell proliferation. Results We observed the expression of SNHG10 was down-regulated in non-small cell lung cancer (NSCLC) compared with that in non-tumor tissues. Moreover, we found that high expression levels of SNHG10 predicted favorable survival of NSCLC patients, and the expression of miR-21 were increased in NSCLC and inversely correlated with SNHG10 expression. In NSCLC cells, overexpression of SNHG10 resulted in increased miR-21 gene methylation and decreased miR-21 expression. Moreover, overexpression of SNHG10 attenuated the enhancing effect of miR-21 overexpression on cell proliferation. Conclusions SNHG10 may involve in NSCLC cell proliferation by regulating the miR-21 gene methylation.
引用
收藏
页数:6
相关论文
共 50 条
[21]   Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients [J].
Zhang, Jiajia ;
Wang, Tong ;
Zhang, Yong ;
Wang, Hao ;
Wu, Yubing ;
Liu, Kunhe ;
Pei, Chong .
CANCER BIOMARKERS, 2018, 21 (04) :763-768
[22]   MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer [J].
Zhiqiang Wang ;
Zhi Li ;
Chen Wu ;
Yonggong Wang ;
Yang Xia ;
Liang Chen ;
Quan Zhu ;
Yijiang Chen .
Medical Oncology, 2014, 31
[23]   Flattened microvessel independently predicts poor prognosis of patients with non-small cell lung cancer [J].
Fang, Luo ;
He, Ying ;
Tong, Yinghui ;
Hu, Luying ;
Xin, Wenxiu ;
Liu, Yujia ;
Zhong, Like ;
Zhang, Yiwen ;
Huang, Ping .
ONCOTARGET, 2017, 8 (18) :30092-30099
[24]   TFPI-2 methylation predicts poor prognosis in non-small cell lung cancer [J].
Wu, Duoguang ;
Xiong, Lihua ;
Wu, Shuoming ;
Jiang, Ming ;
Lian, Guiyong ;
Wang, Minghui .
LUNG CANCER, 2012, 76 (01) :106-111
[25]   MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer [J].
Wang, Zhiqiang ;
Li, Zhi ;
Wu, Chen ;
Wang, Yonggong ;
Xia, Yang ;
Chen, Liang ;
Zhu, Quan ;
Chen, Yijiang .
MEDICAL ONCOLOGY, 2014, 31 (01)
[26]   Mortalin overexpression predicts poor prognosis in early stage of non-small cell lung cancer [J].
Sun, Jie ;
Che, Shuan-Long ;
Piao, Jun-Jie ;
Xu, Ming ;
Chen, Li-Yan ;
Lin, Zhen-Hua .
TUMOR BIOLOGY, 2017, 39 (03)
[27]   Upregulation of lncRNA NCK1-AS1 predicts poor prognosis and contributes to non-small cell lung cancer proliferation by regulating CDK1 [J].
Zha, L-F ;
Zhang, L-D ;
Pan, H-M ;
Ma, H-D .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (03) :1351-1357
[28]   High TMPRSS11D protein expression predicts poor overall survival in non-small cell lung cancer [J].
Cao, Xiang ;
Tang, Zhiyuan ;
Huang, Fang ;
Jin, Qin ;
Zhou, Xiaoyu ;
Shi, Jiahai .
ONCOTARGET, 2017, 8 (08) :12812-12819
[29]   LINK-A lncRNA is upregulated in metastatic non-small cell lung cancer and is associated with poor prognosis [J].
Liu, Junqiang ;
Song, Weian ;
Li, Jun ;
Li, Xuechang ;
Zhao, Rongrong ;
Gong, Taiqian .
ONCOLOGY LETTERS, 2019, 18 (03) :3049-3057
[30]   A molecular and staging model predicts survival in patients with resected non-small cell lung cancer [J].
Liu, Lei ;
Shi, Minxin ;
Wang, Zhiwei ;
Lu, Haimin ;
Li, Chang ;
Tao, Yu ;
Chen, Xiaoyan ;
Zhao, Jun .
BMC CANCER, 2018, 18